Acquiring Company
Northwest Biotherapeutics
Acquired Company
Advent BioServices Ltd
Bethesda
LondonBiotechnologyHealthcareresearchManufacturingBiotechnologyDescription
Northwest Biotherapeutics has announced an agreement to acquire Advent BioServices Ltd. The acquisition will allow Advent to become a wholly owned subsidiary and is expected to enhance the integration of operations and efficiencies. The transaction includes various assets and the transfer of intellectual property. Completion of the acquisition is contingent on legal conditions and is anticipated to yield significant synergies.
Other recent acquisitions in Healthcare and research
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Assertio Holdings acquires Spectrum Pharmaceuticals (September 19, 2025)
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- Edwards Lifesciences acquires Vectorious for $497M, $497M (September 4, 2025)
- AbbVie acquires Gilgamesh Pharmaceuticals' bretisilocin (September 3, 2025)
- AbbVie completes acquisition of Capstan Therapeutics (August 19, 2025)
- ESTEVE acquires Regis Technologies for U.S. expansion (July 31, 2025)
Who to call at Northwest Biotherapeutics, and when
When Northwest Biotherapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Northwest Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Northwest Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Northwest Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Northwest Biotherapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Advent BioServices Ltd?
Advent BioServices Ltd was acquired by Northwest Biotherapeutics, based in Bethesda. The deal was reported on August 27, 2025. Northwest Biotherapeutics is publicly traded (NWBO) and operates in Biotechnology.
When did Northwest Biotherapeutics acquire Advent BioServices Ltd?
Northwest Biotherapeutics's acquisition of Advent BioServices Ltd was reported on August 27, 2025. Northwest Biotherapeutics has announced an agreement to acquire Advent BioServices Ltd. The acquisition will allow Advent to become a wholly owned subsidiary and is expected to enhance the integration of operations and efficiencies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Advent BioServices Ltd do?
Advent BioServices Ltd. is involved in providing contract services in bio-manufacturing and clinical development. They have extensive facilities and capabilities for GMP-compliant production processes. It is privately held, operating in Manufacturing, and is based in London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.